Ozer, Howard
University of Illinois Hospital & Health Sciences System,
United States
2025 Rank: 175,418
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 6,452 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 175,418 | 196,517 |
| Total Cites | 6,580 | 7,104 |
| H-index | 34 | 35 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 64 | 65 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1,013 | 1,058 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 1,764 | 1,860 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,903 | 6,249 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.14 |
| Self-Citation Percentage |
7.38%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 6,466 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 173,541 | 193,005 |
| Total Cites | 6,399 | 6,895 |
| H-index | 33 | 35 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 62 | 63 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1,006 | 1,051 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 1,738 | 1,834 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,730 | 6,051 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
7.19%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 6,137 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162,462 | 180,490 |
| Total Cites | 6,226 | 6,719 |
| H-index | 33 | 35 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 60 | 61 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 997 | 1,042 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 1,715 | 1,811 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,572 | 5,889 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
7.34%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5,761 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152,222 | 171,339 |
| Total Cites | 5,972 | 6,443 |
| H-index | 32 | 33 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 57 | 58 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 977 | 1,022 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 1,672 | 1,767 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,325 | 5,623 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.15 |
| Self-Citation Percentage |
7.31%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.